MedTrace Logo

Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children

NCT01883427 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-01-11

Study results available
· View outcomes & findings →

Summary

To investigate if use of glucosoxidas nasal spray can reduce the number of days with upper respiratory tract infections in children beyond 4 years.

Conditions

  • Upper Respiratory Tract Infections

Interventions

DRUG

Placebo

placebo containing saline+glucose

DRUG

Glucose oxidase

a hydrogen peroxide producing enzyme that creates an acidous environment to which rhinoviruses are sensitive.

Sponsors & Collaborators

  • Krister Tano

    lead OTHER

Principal Investigators

  • Eva Westman, MD, PhD · Västernorrlands Landsting

  • Marie Ryding, MD, PhD · Jämtlands Landsting

  • Anders Niklasson, MD · Norrbottens Landsting

  • Helena Toolanen, MD · Norrbottens Landsting

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-05-31
Completion
2013-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01883427 on ClinicalTrials.gov